nintedanib

GPTKB entity

Statements (35)
Predicate Object
gptkbp:instanceOf gptkb:receptor_tyrosine_kinase
gptkb:drug
gptkbp:approvedBy gptkb:FDA
gptkb:EMA
2014
gptkbp:ATCCode L01XE31
gptkbp:brand gptkb:Ofev
gptkbp:CASNumber 656247-17-5
gptkbp:contraindication severe hepatic impairment
hypersensitivity to nintedanib
gptkbp:developedBy gptkb:Boehringer_Ingelheim
gptkbp:drugClass antineoplastic agent
gptkbp:eliminationHalfLife 9.5 hours
gptkbp:excretion urine
feces
gptkbp:hasMolecularFormula C31H33N5O4
https://www.w3.org/2000/01/rdf-schema#label nintedanib
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction inhibits multiple receptor tyrosine kinases
blocks VEGFR, FGFR, and PDGFR
gptkbp:metabolism hepatic
gptkbp:molecularWeight 539.6 g/mol
gptkbp:pregnancyCategory D (US)
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
vomiting
diarrhea
liver enzyme elevation
gptkbp:usedFor gptkb:non-small_cell_lung_cancer
idiopathic pulmonary fibrosis
systemic sclerosis-associated interstitial lung disease
gptkbp:bfsParent gptkb:Ofev
gptkb:protein_tyrosine_kinases
gptkb:PDGF-B
gptkbp:bfsLayer 7